首页> 美国卫生研究院文献>Springer Open Choice >Cellular binding partners of the human papillomavirus E6 protein
【2h】

Cellular binding partners of the human papillomavirus E6 protein

机译:人乳头瘤病毒E6蛋白的细胞结合伴侣

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The high-risk strains of human papillomavirus (HR-HPV) are known to be causative agents of cervical cancer and have recently also been implicated in cancers of the oropharynx. E6 is a potent oncogene of HR-HPVs, and its role in the progression to malignancy has been and continues to be explored. E6 is known to interact with and subsequently inactivate numerous cellular proteins pivotal in the mediation of apoptosis, transcription of tumor suppressor genes, maintenance of epithelial organization, and control of cell proliferation. Binding of E6 to these proteins cumulatively contributes to the oncogenic potential of HPV. This paper provides an overview of these cellular protein partners of HR-E6, the motifs known to mediate oncoprotein binding, and the agents that have the potential to interfere with E6 expression and activity and thus prevent the subsequent progression to oncogenesis.
机译:人乳头瘤病毒(HR-HPV)的高风险菌株是宫颈癌的病原体,最近还与口咽癌有关。 E6是HR-HPV的有效致癌基因,其在恶性进展中的作用已经并且正在继续被探索。已知E6与许多细胞蛋白相互作用并随后使其失活,这些细胞蛋白在细胞凋亡的介导,肿瘤抑制基因的转录,上皮组织的维持和细胞增殖的控制中起关键作用。 E6与这些蛋白质的结合累积有助于HPV的致癌潜力。本文概述了HR-E6的这些细胞蛋白伴侣,已知介导癌蛋白结合的基序,以及可能干扰E6表达和活性并因此阻止后续发展为肿瘤的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号